Enhanced delivery of iodine for synchrotron stereotactic radiotherapy by means of intracarotid injection and blood–brain barrier disruption: Quantitative iodine biodistribution studies and associated dosimetry
- 1 March 2005
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 61 (4) , 1173-1182
- https://doi.org/10.1016/j.ijrobp.2004.12.026
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Synchrotron radiation-based experimental determination of the optimal energy for cell radiotoxicity enhancement following photoelectric effect on stable iodinated compoundsBritish Journal of Cancer, 2004
- Enhanced Radio Sensitivity with Iodinated Contrast Agents Using Monochromatic Synchrotron X-Rays on Human Cancerous CellsAcademic Radiology, 2002
- First radiotherapy of human metastatic brain tumors delivered by a computerized tomography scanner (CTRx)International Journal of Radiation Oncology*Biology*Physics, 1999
- A comparison of three stereotactic radiotherapy techniques; ARCS vs. noncoplanar fixed fields vs. intensity modulationInternational Journal of Radiation Oncology*Biology*Physics, 1998
- X-ray phototherapy for canine brain massesRadiation Oncology Investigations, 1997
- Diagnosis and treatment of spontaneous canine brain tumors with a CT scannerRadiotherapy and Oncology, 1993
- Synergistic Cytotoxicity of Iodinated Contrast Agents and X-RadiationInvestigative Radiology, 1988
- Iodinated contrast agents as “radiosensitisers”The British Journal of Radiology, 1987
- Radiation dose enhancement therapy with iodine in rabbit VX-2 brain tumorsRadiotherapy and Oncology, 1987
- Radiation dose enhancement in tumors with iodineMedical Physics, 1983